Evoke Pharma Inc. (EVOK)
NASDAQ: EVOK
· Real-Time Price · USD
3.46
-0.09 (-2.53%)
At close: Jun 02, 2025, 3:51 PM
3.56
2.89%
After-hours: Jun 02, 2025, 04:40 PM EDT
Evoke Pharma Revenue Breakdown
| Period Ending | Dec 31, 2024 |
|---|---|
| Pharmaceutical Products Revenue | 10.25M |
| Pharmaceutical Products Revenue Growth | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 4.3M | 4.38M | 3.82M | 3.73M | 3.14M | 3.48M | 3.13M | 2.77M | 2.85M | 2.29M | 2.61M | 2.32M | 2.41M | 1.74M | 2.64M | 2.14M | 2.34M | 2.04M | 1.87M | 1.18M | 1.33M | 782.62K | 814.22K | 918.14K | 1.22M | 1.07M | 897.06K | 917.3K | 1.03M | 1.03M | 984.05K | 871.98K | 1.21M | 822.33K | 830.09K | 802.65K | 1.14M | 842.78K | 819.7K | 976.42K | 1.03M |
| Selling, General, and Administrative Revenue Growth | -1.96% | +14.63% | +2.43% | +18.92% | -9.84% | +11.21% | +13.21% | -2.87% | +24.43% | -12.45% | +12.93% | -3.74% | +38.58% | -34.14% | +23.01% | -8.39% | +14.54% | +8.91% | +58.48% | -11.05% | +69.92% | -3.88% | -11.32% | -24.93% | +13.97% | +19.62% | -2.21% | -11.13% | +0.45% | +4.43% | +12.85% | -27.91% | +47.09% | -0.94% | +3.42% | -29.45% | +35.00% | +2.81% | -16.05% | -4.76% | n/a |
| Research and Development Revenue | 42.78K | n/a | 11.68K | n/a | 4.64K | 22.56K | n/a | 92.36K | 66.99K | 27.21K | 40.39K | 191.48K | 41.72K | 35.72K | 81.7K | 195.23K | 277.82K | 103.85K | 205.03K | 5.78M | 463.85K | 641.54K | 822.44K | 1.21M | 746.88K | 695.36K | 625.5K | 1.39M | 1.39M | 1.63M | 2.72M | 2.02M | 770.69K | 1.5M | 1.34M | 2.1M | 2.02M | 1.71M | 1.84M | 2.19M | 2.42M |
| Research and Development Revenue Growth | n/a | -100.00% | n/a | -100.00% | -79.41% | n/a | -100.00% | +37.87% | +146.22% | -32.64% | -78.91% | +358.99% | +16.78% | -56.27% | -58.15% | -29.73% | +167.54% | -49.35% | -96.45% | +1146.54% | -27.70% | -22.00% | -31.78% | +61.42% | +7.41% | +11.17% | -54.96% | +0.25% | -15.09% | -39.97% | +34.70% | +161.79% | -48.69% | +12.15% | -36.07% | +3.97% | +17.96% | -7.04% | -16.01% | -9.58% | n/a |